miR-99a deregulation has been reported in several human cancers, including breast cancer, and is involved in apoptosis and epithelial-to-mesenchymal transition by regulation of the mTOR, Akt and TGF-β pathway [50–55]. The gene discussed is MTOR; the disease is breast cancer.